Influence of Competing Risks on Estimating the Expected Benefit of Warfarin Among Atrial Fibrillation Patients not Currently Taking Anticoagulants: the ATRIA Study

BACKGROUND/OBJECTIVES: To date, studies examining the association between warfarin therapy and incidence of ischemic stroke among patients with atrial fibrillation (AF) have not accounted for the competing risk of death. Competing risk analysis may provide greater understanding of the “real world” i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Geriatr Soc
Hlavní autoři: Ashburner, Jeffrey M., Go, Alan S., Chang, Yuchiao, Fang, Margaret C., Fredman, Lisa, Applebaum, Katie M., Singer, Daniel E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5258686/
https://ncbi.nlm.nih.gov/pubmed/27861698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.14516
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky